Brazil: Life Sciences, Biotechnology & Nanotechnology

Subscribe
Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.
Article
Atualizações regulatórias em cannabis, biossimilares e mais; confira a newsletter
Regulatory updates from ANVISA, CFM, and CFF shape strategic decisions across pharmaceutical, medical device, and supplementary health sectors. This edition covers key regulatory movements affecting strategic sectors including pharmaceutical industry, supplementary health, food products, and other regulated products, including cases involving regulatory interface with ANVISA and professional councils.
Brazil Healthcare
KL
KLA Advogados
Article
Biocon Enters Ten-Year Pertuzumab Supply Contract In Brazil
Biocon Limited has partnered with Brazilian companies Bahiafarma and Bionovis to secure an exclusive ten-year supply contract for its pertuzumab biosimilar in Brazil's public healthcare market. The partnership aims to improve access to this HER2-positive breast cancer treatment while reducing costs and developing Brazil's domestic pharmaceutical manufacturing capabilities through phased localization.
Brazil Healthcare
GP
Goodwin Procter LLP
Article
Atualizações regulatórias: alimentos, medicamentos, cosméticos e governança sanitária
New regulations and technical adjustments expand compliance requirements, tighten safety criteria, and seek greater efficiency in regulatory processes and market access across Brazil's life sciences sector. This newsletter compiles the most critical regulatory updates affecting pharmaceuticals, supplementary health, food products, and other regulated sectors under ANVISA and professional councils.
Brazil Healthcare
KL
KLA Advogados
See more